BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 36060082)

  • 1. Incidental Findings on
    Broos WAM; Knol RJJ; Zant FMV; Schaper NC; Wondergem M
    World J Nucl Med; 2022 Sep; 21(3):192-199. PubMed ID: 36060082
    [No Abstract]   [Full Text] [Related]  

  • 2.
    Beheshti M; Hehenwarter L; Paymani Z; Rendl G; Imamovic L; Rettenbacher R; Tsybrovskyy O; Langsteger W; Pirich C
    Eur J Nucl Med Mol Imaging; 2018 Sep; 45(10):1762-1771. PubMed ID: 29516131
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Mathey C; Keyzer C; Blocklet D; Van Simaeys G; Trotta N; Lacroix S; Corvilain B; Goldman S; Moreno-Reyes R
    J Nucl Med; 2022 May; 63(5):785-791. PubMed ID: 34413141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preoperative F-18 fluorocholine PET/CT for the detection of hyperfunctioning parathyroid glands in patients with secondary or tertiary hyperparathyroidism: comparison with Tc-99m sestamibi scan and neck ultrasound.
    Chen YH; Chen HT; Lee MC; Liu SH; Wang LY; Lue KH; Chan SC
    Ann Nucl Med; 2020 Aug; 34(8):527-537. PubMed ID: 32436180
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Cuderman A; Senica K; Rep S; Hocevar M; Kocjan T; Sever MJ; Zaletel K; Lezaic L
    J Nucl Med; 2020 Apr; 61(4):577-583. PubMed ID: 31562221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is 18F-fluorocholine-positron emission tomography/computerized tomography a new imaging tool for detecting hyperfunctioning parathyroid glands in primary or secondary hyperparathyroidism?
    Michaud L; Burgess A; Huchet V; Lefèvre M; Tassart M; Ohnona J; Kerrou K; Balogova S; Talbot JN; Périé S
    J Clin Endocrinol Metab; 2014 Dec; 99(12):4531-6. PubMed ID: 25215560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Challenging pre-surgical localization of hyperfunctioning parathyroid glands in primary hyperparathyroidism: the added value of
    Grimaldi S; Young J; Kamenicky P; Hartl D; Terroir M; Leboulleux S; Berdelou A; Hadoux J; Hescot S; Remy H; Baudin E; Schlumberger M; Deandreis D
    Eur J Nucl Med Mol Imaging; 2018 Sep; 45(10):1772-1780. PubMed ID: 29680989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Boccalatte LA; Gómez NL; Musumeci M; Galich AM; Collaud C; Figari MF
    Rev Esp Med Nucl Imagen Mol (Engl Ed); 2020; 39(5):273-278. PubMed ID: 32540340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Performance of F-18 Fluorocholine PET/CT for Detection of Hyperfunctioning Parathyroid Tissue in Patients with Elevated Parathyroid Hormone Levels and Negative or Discrepant Results in conventional Imaging.
    Uslu-Beşli L; Sonmezoglu K; Teksoz S; Akgun E; Karayel E; Pehlivanoglu H; Khosroshahi BR; Ocak M; Kabasakal L; Sager S; Bukey Y
    Korean J Radiol; 2020 Feb; 21(2):236-247. PubMed ID: 31997599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ¹⁸F-Fluorocholine PET/CT for localization of hyperfunctioning parathyroid tissue in primary hyperparathyroidism: a pilot study.
    Lezaic L; Rep S; Sever MJ; Kocjan T; Hocevar M; Fettich J
    Eur J Nucl Med Mol Imaging; 2014 Nov; 41(11):2083-9. PubMed ID: 25063039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dual-Time-Point
    Broos WAM; Wondergem M; van der Zant FM; Knol RJJ
    J Nucl Med; 2019 Nov; 60(11):1605-1610. PubMed ID: 30877179
    [No Abstract]   [Full Text] [Related]  

  • 13. Performance of quantitative measurements in [
    Jacquet-Francillon N; Morelec I; Germain N; Prades JM; Habouzit V; Mariat C; Bonnefoy PB; Prevot N
    Front Med (Lausanne); 2022; 9():956580. PubMed ID: 35983092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Benefit of
    Huber GF; Hüllner M; Schmid C; Brunner A; Sah B; Vetter D; Kaufmann PA; von Schulthess GK
    Eur Radiol; 2018 Jun; 28(6):2700-2707. PubMed ID: 29372312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PETC/CT with
    Bossert I; Chytiris S; Hodolic M; Croce L; Mansi L; Chiovato L; Mariani G; Trifirò G
    J Endocrinol Invest; 2019 Apr; 42(4):419-426. PubMed ID: 30094743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preoperative Imaging with [
    Dekorsy FJ; Beyer L; Spitzweg C; Schmidmaier R; Todica A; Trupka A; Cyran CC; Berger F; Ladurner R; Zimmermann P; Knösel T; Bartenstein P; Lottspeich C; Wenter V
    J Clin Med; 2022 May; 11(10):. PubMed ID: 35629070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Additional value of integrated
    Piccardo A; Trimboli P; Rutigliani M; Puntoni M; Foppiani L; Bacigalupo L; Crescenzi A; Bottoni G; Treglia G; Paparo F; Del Monte P; Lanata M; Paone G; Ferrarazzo G; Catrambone U; Arlandini A; Ceriani L; Cabria M; Giovanella L
    Eur J Nucl Med Mol Imaging; 2019 Mar; 46(3):766-775. PubMed ID: 30219964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidental Detection of a Melanoma by 18F-Fluorocholine PET/CT Performed for Evaluation of Primary Hyperparathyroidism.
    Burgers AMG; Wondergem M; van der Zant FM; Knol RJJ
    Clin Nucl Med; 2018 Apr; 43(4):265-266. PubMed ID: 29356740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Benefits and harms of implementing [
    Vogsen M; Jensen JD; Gerke O; Jylling AMB; Asmussen JT; Christensen IY; Braad PE; Thye-Rønn P; Søe KL; Ewertz M; Hildebrandt MG
    EJNMMI Res; 2021 Sep; 11(1):93. PubMed ID: 34553294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dynamic 18F-fluorocholine PET/CT for parathyroid imaging in patients with primary hyperparathyroidism.
    Broos WAM; Wondergem M; van der Zant FM; Schaper NC; Knol RJJ
    Nucl Med Commun; 2020 Aug; 41(8):776-782. PubMed ID: 32453204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.